A pharmaceutical manufacturing company built around quality, control, and dependable execution.
Meyonex is a pharmaceutical manufacturing company established in 2015, starting with pharmaceutical formulations including liquid orals, tablets, and capsules, and later broadening into dry syrups, ointments, and related formats alongside export-oriented growth. The business is supported by a structured operational environment, manufacturing certified under ISO 9001:2015, and a facility positioned near Jawaharlal Nehru Port Trust (Nhava-Sheva) for efficient domestic and international logistics.
Who We Are
An independent pharmaceutical manufacturer with a broadening formulations footprint.
Meyonex operates as an independent pharmaceutical manufacturing company. The journey began in 2015 with pharmaceutical formulations and early focus on liquid orals, tablets, and capsules; over time the scope expanded to include dry syrups, ointments, and additional dosage support, alongside growing export relationships and organized plant infrastructure.
Our operating philosophy is built around professionalism, accountability, and credibility in pharmaceutical manufacturing. Incorporated in January 2015 and supported by a Tarapur MIDC manufacturing plant inaugurated in August 2022, the company serves domestic and international business requirements through structured manufacturing, packing, and distribution operations, with manufacturing operations certified under ISO 9001:2015.
Installed monthly tablet capacity
Installed monthly capsule capacity
Installed monthly dry powder sachet capacity
Pharmaceutical formulations company
Our Vision
To build a globally respected pharmaceutical manufacturing organization recognized for quality, operational competence, and long-term business trust.
Our vision is to be recognized for operational clarity, quality-focused systems, and a manufacturing environment that supports credible long-term partnerships.
Our Mission
To support domestic and international pharmaceutical markets through dependable manufacturing and disciplined quality systems.
We support pharmaceutical markets through structured production environments, consistent operational oversight, and formulations capability spanning solid and semi-solid dosage workstreams, aligned with scale, quality, and supply confidence.
Manufacturing Profile
Commercial-scale formulations with export-oriented logistics.
Meyonex's manufacturing profile spans tablets, capsules, dry powder sachets, and a widening formulations scope including liquid orals, dry syrups, and ointments. The facility at Tarapur MIDC is structured for commercial-scale output, with installed capacity of 30 Crores tablets, 10 Crores capsules, and 15 Lakhs dry powder sachets per month. The location supports efficient movement of goods domestically and internationally, including proximity to Jawaharlal Nehru Port Trust (Nhava-Sheva). Manufacturing operations are certified under ISO 9001:2015.
Our Capabilities
Built for operational control and manufacturing consistency.
Our facility, environment, quality systems, and production capability are designed to reinforce credibility across the full manufacturing profile.
The Meyonex manufacturing facility is designed to support structured pharmaceutical operations under cGMP-oriented premises planning. The site includes controlled production infrastructure, safety systems, dedicated effluent treatment, epoxy-coated floors, and GMP-aligned architectural features. The unit is situated for logistical access to key transport corridors, including proximity to Jawaharlal Nehru Port Trust (Nhava-Sheva), supporting export-oriented distribution.
- Fire hydrant systems, smoke detectors, fire extinguishers
- Emergency evacuation support and dedicated utility provisions
- Epoxy-coated floors and GMP-aligned finishes
- Dedicated effluent treatment systems
Operational control is supported through facility planning and environmental systems intended to maintain cleaner, more disciplined manufacturing conditions. The site applies unidirectional movement principles for men and materials, dedicated air-handling arrangements, pressure differential monitoring, and classified production areas.
- Unidirectional flow of men and materials
- Door interlocking as part of physical barrier control
- Dedicated air handling for critical production areas
- Classified production environments
- Pressure differential monitoring systems
Meyonex's quality environment is supported by analytical testing capability and process-oriented oversight systems. Manufacturing operations are certified under ISO 9001:2015. The laboratory infrastructure includes HPLC, FTIR, UV spectrophotometry, dissolution testing, stability chambers, autoclaves, incubators, and microbiology-supporting equipment.
- ISO 9001:2015 certification for manufacturing operations
- HPLC, FTIR, UV spectrophotometry
- Dissolution testing and stability chambers
- Autoclaves, incubators, microbiology support
- Audit-trail-oriented data handling systems
The production setup is supported by a broad equipment base across granulation, blending, compression, coating, capsule filling, inspection, and sachet filling. Core equipment includes compression machines with automatic weigh control (AMC), auto coaters, rapid mixer granulators, fluid bed dryers, octagonal blenders, dry powder sachet filling machinery, and tablet inspection with auto-rejection where configured.
- Compression machines with automatic weigh control (AMC)
- Tablet inspection with auto-rejection support on equipped lines
- Auto coaters, rapid mixer granulators, and fluid bed dryers
- Capsule filling and polishing systems
- Dry powder sachet filling machinery
Meyonex maintains an in-house formulation and development setup on the second floor alongside QC and microbiology, staffed by a team of five qualified scientists. The lab supports development-oriented work with equipment spanning granulation, processing, compression, coating, and analytical checks — complementing the broader quality environment without replacing formal QC release functions.
- Rapid mixer granulators, fluid bed processors, compression machines, auto coaters
- HPLC, UV spectrophotometer, potentiometer, EMFC-based analytical balances
- Muffle furnace, precision oven, leak test apparatus, digital hygrometer
- Holmium oxide filter–based wavelength calibration support where used
- Customized product development programmes and CRO-style research collaboration
- Concept-to-prototype work, pilot and stability-oriented studies, scale-up and plant validation, technology transfer, regulatory documentation support, and IP-aware engagement
Our journey
Company milestones
A chronological view of corporate, facility, quality, export, and market-interaction milestones as reflected in Meyonex materials — useful for orientation and diligence conversations.
Important
Entries that mention certificates, plant approval, audits, or delegations repeat wording from source materials. They are not a substitute for licence numbers, validity, scope, or current regulatory status. Confirm all credentials through primary documents and your own verification process.
- Corporate
Company incorporated
- Corporate
Startup India Certificate
- Quality
ISO 9001:2015 (Quality Management System)
- Facility
Manufacturing plant inauguration — Tarapur MIDC
- Quality
GMP Certificate
- Quality
WHO-GMP Certificate
- Market / audit
Plant approved — Zambia
- Market / audit
Plant approved — Nigeria
- Market / audit
Plant approved — Kenya
- Export
Start Export House
- Export
Business delegation to Africa
- Market / audit
Plant approved — Cambodia
- Market / audit
Plant audited — Congolese Pharmaceutical Regulatory Authority (ACOREP)
- Export
Business delegation to CIS
- Market / audit
Plant audited — Ministry of Health, Yemen
- Market / audit
Plant audited — Malawi Ministry of Health
- Market / audit
Plant approved — Ghana
Built for Long-Term Business Confidence
Positioned for domestic and international pharmaceutical partnerships.
Meyonex is positioned to support both domestic and international business requirements through manufacturing capability, operational discipline, quality-focused systems, and export-oriented logistics. The company's documented references include FDA Maharashtra, WHO-CDSCO, and export-linked presence across multiple markets in Africa, Asia, and Europe — see Global Markets for the country list sourced from company materials.
Next Conversation
Discuss your manufacturing requirement with Meyonex.
Connect with our team to explore manufacturing requirements, business inquiries, and long-term partnership opportunities in pharmaceutical production.